| Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance A Visvanathan, V Patil, A Arora, AS Hegde, A Arivazhagan, V Santosh, ... Oncogene 37 (4), 522-533, 2018 | 523 | 2018 |
| A clinically applicable integrative molecular classification of meningiomas F Nassiri, J Liu, V Patil, Y Mamatjan, JZ Wang, R Hugh-White, AM Macklin, ... Nature 597 (7874), 119-125, 2021 | 249 | 2021 |
| Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes F Nassiri, A Chakravarthy, S Feng, SY Shen, R Nejad, JA Zuccato, ... Nature medicine 26 (7), 1044-1047, 2020 | 219 | 2020 |
| Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial F Nassiri, V Patil, LS Yefet, O Singh, J Liu, RMA Dang, TN Yamaguchi, ... Nature medicine 29 (6), 1370-1378, 2023 | 91 | 2023 |
| Methylation silencing of ULK2, an autophagy gene, is essential for astrocyte transformation and tumor growth S Shukla, IRP Patric, V Patil, SD Shwetha, AS Hegde, BA Chandramouli, ... Journal of Biological Chemistry 289 (32), 22306-22318, 2014 | 91 | 2014 |
| N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the … A Visvanathan, V Patil, S Abdulla, JD Hoheisel, K Somasundaram Genes 10 (2), 141, 2019 | 88 | 2019 |
| Glioblastoma-derived macrophage colony-stimulating factor (MCSF) induces microglial release of insulin-like growth factor-binding protein 1 (IGFBP1) to promote angiogenesis MB Nijaguna, V Patil, S Urbach, SD Shwetha, K Sravani, AS Hegde, ... Journal of Biological Chemistry 290 (38), 23401-23415, 2015 | 85 | 2015 |
| Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing V Patil, J Pal, K Somasundaram Oncotarget 6 (41), 43452, 2015 | 80 | 2015 |
| Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy VS Tomar, V Patil, K Somasundaram Cell Biology and Toxicology 36, 273-278, 2020 | 72 | 2020 |
| Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration B Mondal, V Patil, SD Shwetha, K Sravani, AS Hegde, A Arivazhagan, ... Oncogene 36 (1), 71-83, 2017 | 50 | 2017 |
| PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA Z Nawaz, V Patil, Y Paul, AS Hegde, A Arivazhagan, V Santosh, ... Molecular cancer 15, 1-16, 2016 | 50 | 2016 |
| Epigenetically silenced GNG4 inhibits SDF1α/CXCR4 signaling in mesenchymal glioblastoma J Pal, V Patil, B Mondal, S Shukla, AS Hegde, A Arivazhagan, V Santosh, ... Genes & Cancer 7 (3-4), 136, 2016 | 44 | 2016 |
| Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma A Arora, V Patil, P Kundu, P Kondaiah, AS Hegde, A Arivazhagan, ... Scientific reports 9 (1), 2749, 2019 | 43 | 2019 |
| Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription Z Nawaz, V Patil, A Arora, AS Hegde, A Arivazhagan, V Santosh, ... Scientific reports 6 (1), 27753, 2016 | 39 | 2016 |
| Genome-wide ChIP-seq analysis of EZH2-mediated H3K27me3 target gene profile highlights differences between low-and high-grade astrocytic tumors V Sharma, PB Malgulwar, S Purkait, V Patil, P Pathak, R Agrawal, ... Carcinogenesis 38 (2), 152-161, 2017 | 35 | 2017 |
| Definition of a serum marker panel for glioblastoma discrimination and identification of Interleukin 1β in the microglial secretome as a novel mediator of endothelial cell … MB Nijaguna, C Schröder, V Patil, SD Shwetha, AS Hegde, ... Journal of proteomics 128, 251-261, 2015 | 34 | 2015 |
| Temozolomide‐modulated glioma proteome: Role of interleukin‐1 receptor‐associated kinase‐4 (IRAK 4) in chemosensitivity DM Kumar, V Patil, B Ramachandran, MV Nila, K Dharmalingam, ... Proteomics 13 (14), 2113-2124, 2013 | 33 | 2013 |
| Loss-of-Function Mutations in Calcitonin Receptor (CALCR) Identify Highly Aggressive Glioblastoma with Poor Outcome J Pal, V Patil, A Kumar, K Kaur, C Sarkar, K Somasundaram Clinical Cancer Research 24 (6), 1448-1458, 2018 | 32 | 2018 |
| An eighteen serum cytokine signature for discriminating glioma from normal healthy individuals MB Nijaguna, V Patil, AS Hegde, BA Chandramouli, A Arivazhagan, ... PloS one 10 (9), e0137524, 2015 | 32 | 2015 |
| DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas Y Paul, B Mondal, V Patil, K Somasundaram Clinical epigenetics 9, 1-18, 2017 | 31 | 2017 |
